Belonging starts in the body. When nerve damage occurs, it disrupts sensation that affects physical function and severs bonds with what brings us joy and makes us who we are. We restore what it means to be human – feeling alive and connected to the world again.
Solaxa is a clinical-stage biopharmaceutical company developing life-altering solutions that reignite function lost from neurodegenerative disease and nerve damage. We help adults and children get back the confidence in movement and the ability to participate in activities that bring a sense of belonging.
As a public benefit corporation, we have a responsibility to deliver impactful solutions; we serve people for the greater good. We measure success by the human experience — by delivering solutions and care that help people regain independence and the ability to connect with the world around them. Because when you feel at home in your body, you belong everywhere.
Company Details
- Employees
- 10
- Founded
- -
- Address
- 7272 Wisconsin Ave,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.solaxa.com
- Keywords
- Biotechnology, Pharmaceuticals, Nerves, Research, Therapeutics, CIPN, Nerve Injury, ataxia, SCA27b, Peripheral Neuropathy, spinocerebellar ataxia, CNS, Neurology.
- HQ
- Bethesda, Maryland
Solaxa Questions
Solaxa's website is http://www.solaxa.com
Solaxa's LinkedIn profile is https://www.linkedin.com/company/solaxa
Solaxa has
10 employees.
View email and phone details for 10
employees at Solaxa.
Solaxa's industry is
Biotechnology Research
Solaxa's top competitors are
National Ataxia Foundation,
Biohaven,
Angel Star Ventures, Llc,
Acorda Therapeutics, Inc.,
Adovate,
Kapsul Advisors,
Nuvation Bio,
Clinical Data Science Gmbh,
Institute For Biohealth Innovation,
Urogen Pharma.
Solaxa's categories are Biotechnology Research
Solaxa's founding year is 2021
